Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Board/Management Information 2022

Jan 31, 2022

61842_rns_2022-01-31_385d9314-b397-439d-83e3-bacc5548d940.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Communication Address : Solara Active Pharma Sciences Limited Batra Centre No. 28, Sardar Patel Road, Post Box 2630 Guindy, Chennai - 600 032, India Tel: +91 44 43446700, 22207500 Fax: +91 44 22350278 E-mail: [email protected] www.solara.co.in

January 31, 2022

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001

Scrip Code: 541540

Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051

The National Stock Exchange of India Limited

Scrip Code: SOLARA

Dear Sirs.

Sub: Announcement of Board Meeting under Regulation 29 (1) of SEBI Listing Regulations

This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, February 9, 2022 to inter alia consider and approve, the unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months period ended December 31, 2021, amongst other matters.

In accordance with the Company's Code of Conduct to regulate, monitor and report trading by insiders, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from January 1, 2022 till 48 hours after the announcement of financial results i.e. upto February 11, 2022 (both days inclusive).

This is for your information and appropriate dissemination.

Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited

S. Murali Krishna Company Secretary